Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

Influenza Vaccine Responses as a Means of Assessing Immune Competence in Chimeric Kidney/Stem Cell Transplant Recipients

A legfontosabb adatok

Ki végzi
Northwestern University
Hol
Chicago (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
19 fő vett részt
Kezdés
2015. okt.
Befejezés
2023. dec.
A vizsgálat típusa
Megfigyeléses, 3 csoport
A vizsgált kezelések
  • Influenza vaccine
A regiszteradat frissítve
2025. május 16.

Ki vehet részt

Életkor
18 év felett
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 5 feltétel megnézéseKevesebb

Ki vehet részt

  • Adults who have received either a combined kidney/stem cell transplant and have achieved chimerism or post-transplant recipients who are maintained on standard immunosuppressive therapy. Additionally, healthy controls of either gender ≥ 18 years of age will also be recruited
  • Subjects must be willing and able to receive the IIV4 and provide blood samples at research visits
  • Subjects must be willing and able to read, understand, and be capable of giving informed consent for prospective enrollment

Ki nem vehet részt

  • Any condition that, in the opinion of the attending physician, would place the patient at undue risk by participating. Specific conditions include but are not limited to anemia prohibitive of phlebotomy, coagulopathy or inability to receive the IIV4
  • Subjects less than 18 years of age

Helyszínek itt: Egyesült Államok

  • Northwestern University-Comprehensive Transplant CenterChicago, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

Influenza infection in solid organ transplant recipients is associated with increased morbidity and mortality compared to non-transplanted controls, due in part to the effects of immunosuppression which is necessary to prevent rejection of the transplanted organ. However, transplant patients are less likely to produce antibodies when vaccinated and when they do, the peak and duration of antibody responses are reduced compared to healthy controls. There are considerable differences in the magnitude of these responses, reflecting variability in individual responses to the influenza vaccine and to the immunosuppression regimen. The investigators hypothesize that chimeric kidney transplant recipients off of immunosuppression will have post vaccine immune responses that are comparable to age and gender matched healthy controls.

A vizsgálat 3 csoportja

  • Transplant recipients (Chimeric)

    Adults who have received a kidney/stem cell transplant and have achieved chimerism will receive the IIV4 (influenza vaccine).

    Kezelés: Influenza vaccine

  • Transplant recipients (IS)

    Adults who have received a kidney/stem cell transplant and are currently maintained on standard immunosuppressive therapy will receive the IIV4 (influenza vaccine).

    Kezelés: Influenza vaccine

  • Controls

    Healthy adults who meet inclusion and exclusion criteria will receive the IIV4 (influenza vaccine).

    Kezelés: Influenza vaccine

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
A regiszteradat frissítve
2025. május 16.